Stem Cells + Glutathione for Autism

This trial aims to explore the safety and effectiveness of combining stem cells with a natural antioxidant called glutathione for people with Autism Spectrum Disorder (ASD). Participants will receive either the stem cell treatment (AdiaVita, which includes umbilical cord blood-derived stem cells and exosomes) with glutathione or glutathione alone to assess improvements in autism-related behaviors. Individuals diagnosed with ASD and open to experimental treatments may be suitable candidates. The trial is experimental and involves potential risks, such as reactions to infusions. Participants must cover some costs and attend regular study visits. As a Phase 1 trial, this research focuses on understanding the treatment's effects in people, offering participants the opportunity to be among the first to receive this innovative therapy.

The trial does not specify if you must stop taking your current medications, but it requires a stable medication regimen without frequent changes or missed doses in the 30 days before starting. It's best to discuss your specific situation with the trial team.

Research shows that treatments using stem cells from umbilical cord blood, such as AdiaVita, are under investigation for their potential to manage autism symptoms. These stem cells might adjust or repair the immune system in individuals with autism. However, since this trial is in its early stages, the safety of using AdiaVita with glutathione, an antioxidant, remains unclear.

Most treatments for autism focus on behavioral therapy or medications to manage symptoms. But AdiaVita offers a different approach by using umbilical cord blood-derived stem cells and exosomes. Researchers are excited because this treatment could potentially address the underlying biological aspects of autism, rather than just the surface symptoms. The combination of stem cells with glutathione is thought to promote brain repair and reduce inflammation, which could lead to more comprehensive improvements in autism symptoms. This innovative approach provides a fresh perspective on how we might better help those with autism.

Research has shown that stem cells from umbilical cord blood, like those in AdiaVita, might help with autism spectrum disorder (ASD). These stem cells could manage the body's immune system and reduce inflammation, potentially improving ASD symptoms. In previous studies, about 70% of children experienced improvements in key autism symptoms after receiving similar treatments. This trial will compare two treatment arms: one where participants receive Glutathione with Stem Cells, and another where participants receive Glutathione Only. Additionally, mesenchymal stem cells and their tiny particles that facilitate cell communication have shown potential in enhancing social skills and emotional expression in people with ASD. While these results are encouraging, it is important to note that this treatment is still under study and not yet approved by the FDA for autism.⁶⁷⁸⁹¹⁰